成都先導(688222.SH):目前成都先導1.2萬億分子的DEL庫化合物空間巨大
格隆匯9月22日丨成都先導(688222.SH)接受特定對象調研時表示,DEL庫篩選的速度快,週期短,一般3-6個月時長。之前的3年排他期造成很多高價值靶點無法有效利用DEL龐大的化合物庫資源,為更多客户產生苗頭化合物。目前成都先導1.2萬億分子的DEL庫化合物空間巨大,多個客户能從不同的篩選中獲得不同的化合物系列,並擁有各自有獨立的化合物空間和權益。我們將靶點排他期改為1年,是為了讓更多的客户不因靶點排他期而無法使用萬億級編碼化合物庫。公司的1年靶點排他期調整的是對靶標篩選的獨佔期,不會影響到篩選結果中化合物的知識產權,客户從先導獲得授權的化合物具有終身權益,並可自行進行專利申請。所以縮短篩選的靶標獨佔期(排他期)不會影響客户對先導的信任和客户黏性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.